MPO and plasma cell myeloma: MPO modifies the bone marrow microenvironment with increases in IL6, VEGFa and CCL2 stromal expression, and a reduction in IFN‐γ positive cytotoxic T‐cells, providing a supportive niche for myeloma plasma cell growth.